Recent Hikma Pharmaceuticals News

Investing Articles

Growth, value AND dividends. I think this FTSE 100 stock looks attractive right now

Looking for shares to buy right now? This under-the-radar FTSE 100 (INDEXFTSE: UKX) stock offers growth, value, and dividends, says…

Read more »

Investing Articles

These 2 FTSE 100 growth stocks I like are climbing while markets crash

Not every stock on the FTSE 100 (INDEXFTSE:UKX) is falling today.

Read more »

Investing Articles

An overlooked ex-FTSE 100 dividend stock I’d buy and hold forever

Roland Head explains why he'd buy this former FTSE 100 (INDEXFTSE: UKX) stock, despite its recent demotion to the FTSE…

Read more »

Investing Articles

Why I’d snap up this FTSE 100 pharmaceutical provider alongside GlaxoSmithKline

I like GlaxoSmithKline plc (LON: GSK), but I also think today’s update from this smaller FTSE 100 (INDEXFTSE: UKX) competitor…

Read more »

Investing Articles

3 FTSE 100 shares I’d snap up for my Stocks and Shares ISA

The FTSE 100 index (INDEXFTSE: UKX) is packed with great shares and here are three that I like.

Read more »

Investing Articles

2 dividend stocks I’d buy for an ISA today

These dividend stocks could be big winners over the next decade, says Roland Head.

Read more »

Investing Articles

Could this FTSE 100 stock double your money again?

G A Chester discusses the outlook for this FTSE 100 (INDEXFTSE:UKX) big winner and a smaller-cap peer.

Read more »

Investing Articles

I think these 2 fast-recovering FTSE 250 pharma growth stocks could make you richer

Harvey Jones says these two FTSE 250 (INDEXFTSE: MCX) stocks are in fine form after a sickly year.

Read more »

Investing Articles

FTSE 100 crash? Is this the best stock to hold in case it happens?

Should you be looking for 'picks-and-shovels' plays in case the FTSE 100 (INDEXFTSE: UKX) is heading for a fall?

Read more »

Investing Articles

Is Hikma Pharmaceuticals the hottest growth stock in the FTSE 250?

FTSE 250 (INDEXFTSE: MCX) growth stock Hikma Pharmaceuticals plc (LON: HIK) is up 120% since March. Are there more gains…

Read more »

Investing Articles

Why I’d buy this FTSE 250 flyer alongside AstraZeneca plc

I reckon there is more to come for investors from this pharmaceutical company and from AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

Why is the Burberry share price up 20% so far this year?

Shares in Burberry Group plc (LON:BRBY) are riding high as the luxury fashion house makes good progress on its turnaround.

Read more »

Investing Articles

2 super growth stocks I’d buy with £5,000 today

Just £5,000 could help you make a fortune with these super growth stocks.

Read more »

Investing Articles

2 cheap growth stocks I’d buy for the long term

These two shares could offer a mix of growth and value in current market conditions.

Read more »

Investing Articles

2 FTSE 250 pharma stocks I’d buy today and hold for another five years

Roland Head takes a look at two unusual pharma stocks with long-term growth potential.

Read more »

Investing Articles

Provident Financial plc isn’t the only turnaround stock I’m considering buying for my ISA

G A Chester discusses whether Provident Financial plc (LON:PFG) and another fallen growth star are now brilliant recovery buys.

Read more »

Investing Articles

Two defensive growth stocks I’d buy and hold for 10 years

These two stocks are struggling today but the future could still be bright.

Read more »

Investing Articles

2 turnaround stocks I’d consider buying before 2018

Could these two turnaround stocks beat the market in 2018 and beyond?

Read more »

Investing Articles

Are these two beaten-up FTSE 250 turnaround plays buys after today’s results?

Harvey Jones says these FTSE 250 (INDEXFTSE:MCX) stocks could reward further investigation despite patchy results.

Read more »

Investing Articles

Why I’d buy this FTSE 250 stock alongside AstraZeneca plc

I think AstraZeneca plc (LON: AZN) pairs well with this FTSE 250 (INDEXFTSE: MCX) player.

Read more »

Investing Articles

2 growth stocks for the long run

These two stocks could perform well in future years.

Read more »

Investing Articles

2 turnaround stocks that could make you rich

Bilaal Mohamed picks out two battered pharmaceutical stocks that could turn out to be excellent recovery plays.

Read more »

Investing Articles

There could be hidden value in these FTSE 250 stocks

G A Chester discusses his two top-value picks from the FTSE 250 (INDEXFTSE:MCX).

Read more »

Investing Articles

Why this battered pharma stock could be a top turnaround buy

Roland Head selects his turnaround pick from two of this year's biggest pharma fallers.

Read more »

Investing Articles

Hikma Pharmaceuticals plc’s pain could be GlaxoSmithKline plc’s gain

Could ongoing approval issues at Hikma Pharmaceuticals plc (LON: HIK) and rivals help GlaxoSmithKline plc (LON:GSK) preserve its dividend?

Read more »

Airplane sitting on a runway
Investing Articles

These 2 battered stocks look set for a return to growth

These two hot recovery prospects certainly carry some risk, but they could provide great rewards for brave investors.

Read more »

Investing Articles

2 FTSE 350 growth stocks I’d buy ASAP

Now could be the perfect time to pick up shares in these two FTSE 350 (INDEXFTSE:NMX) growth companies.

Read more »

Investing Articles

Are these bombed-out pharma stocks worth buying?

Should you catch these falling knives?

Read more »

Investing Articles

2 ‘hot’ growth stocks I’d buy before it’s too late

Bilaal Mohamed explains why investors should consider these growth stocks before it's too late.

Read more »

Investing Articles

Why I’d buy and hold Hikma Pharmaceuticals plc for the next decade

Hikma Pharmaceuticals plc (LON: HIK) could be a stunning long-term growth stock.

Read more »

Investing Articles

2 FTSE 100 growth stocks to buy before it’s too late?

Royston Wild discusses the investment potential of two FTSE 100 (INDEXFTSE: UKX) growth shares.

Read more »

Investing Articles

These FTSE 100 stocks rocketed 20% in February. Can they keep going?

Royston Wild runs the rule over two FTSE 100 (INDEXFTSE: UKX) chargers.

Read more »

Investing Articles

Why this growth stock could soar 40%+ within 2 years

Stunning gains could be on the horizon for this company.

Read more »

Investing Articles

A dividend stock and a growth stock I’d buy in February

Edward Sheldon identifies a dividend powerhouse and a growth stock that offer value at present.

Read more »

Investing Articles

Why I see 50% upside in this pharmaceutical firm in 2017

Bilaal Mohamed explains why this pharamceutical firm could have massive growth potential over the coming year.

Read more »

Investing Articles

Kick-start 2017 with these explosive growth stocks

Bilaal Mohamed thinks these two pharmacetutical firms could be on the verge of spectacular gains in 2017.

Read more »

Investing Articles

2 top healthcare shares for growth investors right now

Are these the best healthcare stocks to buy for 2017?

Read more »

Investing Articles

Could Vectura Group plc grow to be a FTSE 100 company within 10 years?

Vectura Group plc (LON:VEC) could follow in the footsteps of Hikma Pharmaceuticals (LON:HIK), says G A Chester.

Read more »

Investing Articles

Which of these Footsie healthcare stars should you buy after today’s news?

Royston Wild discusses the investment prospects of two Footsie medical giants.

Read more »

Investing Articles

Why did shares in Hikma Pharmaceuticals plc and GlaxoSmithKline plc crash last week?

Shares in GlaxoSmithKline plc (LON: GSK) and Hikma Pharmaceuticals plc (LON: HIK) are crashing but should you sell?

Read more »